Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil · Delayed Price · Currency is BRL 9.08
+0.27 (3.06%)
Aug 19, 2026, 5:05 PM GMT-3
Blau Farmacêutica Financials Overview
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,786 | 1,702 | 1,754 | 1,373 | 1,407 | 1,366 |
Revenue Growth | 1.06% | -2.96% | 27.81% | -2.44% | 2.96% | 15.62% |
Gross Profit Gross Profit Growth | 738.36 | 682.74 | 658.75 | 490.25 | 667.88 | 665.93 |
Operating Income Operating Income Growth | 308.71 | 354.39 | 328.8 | 448.28 | 452.19 | 456.62 |
Net Income Net Income Growth | 225.81 | 294.96 | 217.21 | 249.81 | 363.37 | 325.22 |
Earnings Per Share EPS Growth | - | 1.28 | 0.94 | 1.08 | 1.57 | 1.39 |
EPS Growth | - | 35.80% | -13.05% | -31.18% | 12.69% | 12.33% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Retail+Aesthetics+Plasma Retail+Aesthetics+Plasma Growth | 268.99 | 231.86 | 192 | 131 | 97.85 |
Hospital Hospital Growth | 1,433 | 1,523 | 1,181 | 1,276 | 1,269 |
Total Total Growth | 1,702 | 1,754 | 1,373 | 1,407 | 1,366 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 884.87 | 615.09 | 492.87 | 407.31 | 643.65 | 922.82 |
Total Debt Total Debt Growth | 853.09 | 599.13 | 558.95 | 608.54 | 311.71 | 374.52 |
Net Cash (Debt) Net Cash Growth | 31.78 | 15.95 | -66.08 | -201.22 | 331.93 | 548.3 |
Net Cash Growth | - | - | - | - | -39.46% | - |
Net Cash Per Share Net Cash Per Share Growth | - | 0.07 | -0.29 | -0.87 | 1.44 | 2.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 414.76 | 290.84 | 507.2 | 220.56 | 171.9 | 154.13 |
Capital Expenditures CapEx Growth | -193.61 | -262.04 | -142.67 | -149.42 | -142.66 | -148.2 |
Free Cash Flow Free Cash Flow Growth | 221.15 | 28.8 | 364.53 | 71.14 | 29.24 | 5.93 |
Free Cash Flow Growth | 3.57% | -92.10% | 412.43% | 143.26% | 392.80% | -95.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 41.34% | 40.11% | 37.55% | 35.72% | 47.47% | 48.74% |
Operating Margin | 17.28% | 20.82% | 18.74% | 32.66% | 32.14% | 33.42% |
Pretax Margin | 16.81% | 22.82% | 16.64% | 24.35% | 33.30% | 35.31% |
Profit Margin | 12.64% | 17.33% | 12.38% | 18.20% | 25.83% | 23.80% |
FCF Margin | 12.38% | 1.69% | 20.78% | 5.18% | 2.08% | 0.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.355 | - | - | 0.295 | 0.495 |
Dividend Per Share Growth | 0% | - | - | -40.40% | - |
Dividend Yield | 4.03% | - | - | 2.66% | 2.83% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.29 | 8.46 | 10.76 | 11.67 | 12.88 | 20.08 |
Forward PE | 6.86 | 8.14 | 8.13 | 12.65 | 11.36 | 15.20 |
P/FCF Ratio | 9.48 | 86.67 | 6.41 | 40.99 | 160.06 | 1100.43 |
PS Ratio | 1.17 | 1.47 | 1.33 | 2.12 | 3.33 | 4.78 |